• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

频繁住院 COPD 患者的预后:气道感染的作用。

Prognosis of COPD patients requiring frequent hospitalization: role of airway infection.

机构信息

Respiratory Department, Hospital Joan March, Carretera Palma-Soller km 12,5, 07110 Bunyola, Balearic Island, Spain.

出版信息

Respir Med. 2010 Jun;104(6):840-8. doi: 10.1016/j.rmed.2009.12.010. Epub 2010 Jan 27.

DOI:10.1016/j.rmed.2009.12.010
PMID:20106648
Abstract

RATIONALE

A subgroup of patients with chronic obstructive pulmonary disease require frequent hospitalization because of exacerbations of the disease. We hypothesized that airway infection by non-usual pathogens is a major factor driving hospitalization needs in these patients.

OBJECTIVES

  1. To describe the clinical and functional characteristics of a cohort of COPD patients requiring > or =2 hospitalizations per year; 2) to determine prospectively their microbiological pattern during exacerbations; and, 3) to analyze the prognostic value of several clinical, functional and microbiological variables with respect to hospitalizations and mortality.

METHODS

Open cohort study of 116 COPD patients who had been hospitalized at least twice during the last 12 months. Patients were followed for an average of 21 months.

MEASUREMENTS AND MAIN RESULTS

Clinical data, forced spirometry and 6min walking distance were determined, and the BODE index was calculated, at the time of inclusion in the study. During follow-up, sputum culture was obtained during exacerbations, and hospitalization and mortality were collected every two months. Mean age was 71 yrs, and 94% of patients were male. Main findings show that: 1) not all patients had severe disease according to either the degree of airflow limitation or the BODE index; 2) non-usual pathogens, mainly Pseudomonas aeruginosa, other gram-negative non-fermentative rods and Enterobacteriaceae, were isolated among 71.1% of the sputum obtained during exacerbations; and, 3) these pathogens were associated with poor prognosis and frequent hospitalization.

CONCLUSIONS

Airway infection by non-usual pathogens appears to be a key driver of frequent hospitalizations and mortality in COPD.

摘要

背景

慢性阻塞性肺疾病(COPD)患者中有一部分亚群因疾病加重而需要频繁住院治疗。我们假设,非典型病原体引起的气道感染是导致这些患者住院需求的主要因素。

目的

1)描述每年需要 > 或 =2 次住院治疗的 COPD 患者队列的临床和功能特征;2)前瞻性确定他们在加重期的微生物学模式;3)分析几个临床、功能和微生物学变量对住院和死亡率的预后价值。

方法

这是一项开放队列研究,纳入了 116 名在过去 12 个月内至少住院两次的 COPD 患者。患者平均随访 21 个月。

测量和主要结果

在研究纳入时,确定了临床数据、用力肺活量和 6 分钟步行距离,并计算了 BODE 指数。在随访期间,在加重期采集痰培养,并每两个月收集一次住院和死亡情况。患者的平均年龄为 71 岁,94%为男性。主要发现如下:1)并非所有患者根据气流受限程度或 BODE 指数都有严重疾病;2)在加重期获得的痰标本中,有 71.1%分离出非典型病原体,主要是铜绿假单胞菌、其他革兰氏阴性非发酵菌和肠杆菌科;3)这些病原体与不良预后和频繁住院相关。

结论

非典型病原体引起的气道感染似乎是 COPD 患者频繁住院和死亡的关键驱动因素。

相似文献

1
Prognosis of COPD patients requiring frequent hospitalization: role of airway infection.频繁住院 COPD 患者的预后:气道感染的作用。
Respir Med. 2010 Jun;104(6):840-8. doi: 10.1016/j.rmed.2009.12.010. Epub 2010 Jan 27.
2
Pseudomonas aeruginosa and mortality after hospital admission for chronic obstructive pulmonary disease.铜绿假单胞菌与慢性阻塞性肺疾病患者住院后的死亡率。
Respiration. 2012;84(1):36-43. doi: 10.1159/000331224. Epub 2011 Oct 12.
3
Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa.台湾慢性阻塞性肺疾病急性加重住院患者的痰液细菌学,重点关注肺炎克雷伯菌和铜绿假单胞菌。
Respirology. 2007 Jan;12(1):81-7. doi: 10.1111/j.1440-1843.2006.00999.x.
4
Yield of sputum microbiological examination in patients hospitalized for exacerbations of chronic obstructive pulmonary disease with purulent sputum.因慢性阻塞性肺疾病急性加重伴脓性痰住院患者的痰微生物学检查结果
Respiration. 2007;74(1):19-25. doi: 10.1159/000093158. Epub 2006 May 3.
5
Prediction of risk of COPD exacerbations by the BODE index.采用BODE指数预测慢性阻塞性肺疾病急性加重的风险。
Respir Med. 2009 Mar;103(3):373-8. doi: 10.1016/j.rmed.2008.10.004. Epub 2008 Nov 17.
6
Predictors of positive sputum cultures in exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病加重期痰液培养阳性的预测因素。
Respirology. 2009 Nov;14(8):1114-20. doi: 10.1111/j.1440-1843.2009.01615.x. Epub 2009 Sep 16.
7
[Pseudomonas aeruginosa in chronic obstructive pulmonary disease].[慢性阻塞性肺疾病中的铜绿假单胞菌]
Rev Med Suisse. 2010 Nov 24;6(272):2240-3.
8
Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重的微生物学决定因素
Arch Intern Med. 2005 Apr 25;165(8):891-7. doi: 10.1001/archinte.165.8.891.
9
Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients.严重加重和 BODE 指数:男性 COPD 患者死亡的两个独立危险因素。
Respir Med. 2009 May;103(5):692-9. doi: 10.1016/j.rmed.2008.12.005. Epub 2009 Jan 7.
10
Sputum color as a marker of acute bacterial exacerbations of chronic obstructive pulmonary disease.痰液颜色作为慢性阻塞性肺疾病急性细菌感染加重的一项指标。
Respir Med. 2005 Jun;99(6):742-7. doi: 10.1016/j.rmed.2004.10.020. Epub 2004 Dec 10.

引用本文的文献

1
Activation of Automatic Tube Compensation Mode Attenuates Auto-PEEP in Chronic Obstructive Pulmonary Disease Patients.自动管补偿模式的激活可减轻慢性阻塞性肺疾病患者的自动 PEEP。
Clin Respir J. 2024 Oct;18(10):e70028. doi: 10.1111/crj.70028.
2
Accelerated Lung Function Decline and Mucus-Microbe Evolution in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病中肺功能加速下降与黏液-微生物演变。
Am J Respir Crit Care Med. 2024 Aug 1;210(3):298-310. doi: 10.1164/rccm.202306-1060OC.
3
Mortality and exacerbations associated with Stenotrophomonas maltophilia in chronic obstructive pulmonary disease. A regional cohort study of 22,689 outpatients.
与嗜麦芽寡养单胞菌相关的慢性阻塞性肺疾病患者的死亡率和恶化率。一项针对 22689 名门诊患者的区域性队列研究。
Respir Res. 2023 Sep 26;24(1):232. doi: 10.1186/s12931-023-02544-w.
4
Predictors of mortality in chronic obstructive pulmonary disease: a systematic review and meta-analysis.慢性阻塞性肺疾病患者死亡的预测因素:系统评价和荟萃分析。
BMC Pulm Med. 2022 Apr 4;22(1):125. doi: 10.1186/s12890-022-01911-5.
5
Use of inhaled corticosteroids and risk of acquiring in patients with chronic obstructive pulmonary disease.吸入皮质类固醇与慢性阻塞性肺疾病患者感染风险的相关性。
Thorax. 2022 Jun;77(6):573-580. doi: 10.1136/thoraxjnl-2021-217160. Epub 2021 Aug 26.
6
Antibiotic treatment adequacy and death among patients with Pseudomonas aeruginosa airway infection.铜绿假单胞菌气道感染患者的抗生素治疗充分性与死亡。
PLoS One. 2019 Dec 31;14(12):e0226935. doi: 10.1371/journal.pone.0226935. eCollection 2019.
7
Profiling of lung microbiota discloses differences in adenocarcinoma and squamous cell carcinoma.肺微生物组分析揭示了腺癌和鳞状细胞癌的差异。
Sci Rep. 2019 Sep 6;9(1):12838. doi: 10.1038/s41598-019-49195-w.
8
Microorganisms resistant to conventional antimicrobials in acute exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期对抗生素耐药的微生物。
Respir Res. 2018 Jun 15;19(1):119. doi: 10.1186/s12931-018-0820-1.
9
Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation.慢性阻塞性肺疾病(COPD)合并反复急性加重患者的治疗:感染与炎症的作用
Int J Chron Obstruct Pulmon Dis. 2016 Mar 11;11:515-25. doi: 10.2147/COPD.S98333. eCollection 2016.
10
Metagenomic Sequencing of the Chronic Obstructive Pulmonary Disease Upper Bronchial Tract Microbiome Reveals Functional Changes Associated with Disease Severity.慢性阻塞性肺疾病上呼吸道微生物群的宏基因组测序揭示了与疾病严重程度相关的功能变化。
PLoS One. 2016 Feb 12;11(2):e0149095. doi: 10.1371/journal.pone.0149095. eCollection 2016.